Disruptive innovation provides NHS Trusts faster access to continuous IV monitoring to reduce avoidable extravasation harmNEWPORT NEWS, Va. and LONDON, July 22, 2026 /PRNewswire/ -- ivWatch ...
NEWPORT NEWS, Va. and LONDON, July 22, 2026 /PRNewswire/ -- ivWatch, the IV safety company, today announced that its ...
The opening ceremony centred on the importance of movement for people living with rheumatic and musculoskeletal diseases (RMD ...
Disclaimer: The information contained in this article reflects the latest available scientific evidence, personal experiences and opinions of the speakers and not necessarily those of IPSEN.
YouTube Shows lets YPP creators organize videos into seasons and episodes, convert playlists into structured series, and ...
13d
The Russian Armed Forces have begun the dismemberment of the Dobropolsky defensive area — summary
EADaily, July 9th, 2026. The Russian army began to dismember the Dobropolsky defensive area of the Armed Forces of Ukraine, ...
Heartflow Plaque StagingTM, the only staging tool based on total plaque volume*, is now included with every Heartflow Plaque AnalysisData from ...
Presentation at SLEEP 2026 illustrates ability to convert non-responders into responders using personalized programming LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today ...
Following this week's launch of MiniMed Go™, MiniMed will bring hands-on demonstrations of the system and new clinical data NORTHRIDGE, Calif., May 27, 2026 /PRNewswire/ -- MiniMed (Nasdaq: MMED), a ...
Earnings call Alligator Bioscience delivered a steady Q1 2026, maintaining operating costs at SEK 17 million and securing SEK 90 million from warrant exercises, with a cash runway to mid-Q3. The ...
Description: 👉 How to write the rule of a function given the table of values. To write the rule of a function from the table is somehow tricky but can be made easier by having prior knowledge of the ...
“Best of both modalities” approach combines the efficacy, safety and scalability of RNA therapeutics with the multi-year durability of gene therapies Portfolio prioritizes rare, severe, lifelong ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results